FDA-cleared profile

Kosmos

EchoNous, Inc. · Ultrasound · FDA-cleared (510(k))

Kosmos acquires, processes, displays, measures, and stores ultrasound with synchronized ECG and digital auscultation across cardiac, lung, abdominal, vascular, musculoskeletal, and interventional applications. Adult-only Auto EF and AI FAST are adjunct functions.

Clinical role
Point-of-care ultrasound acquisition, measurement, auscultation, adult ejection-fraction assistance, and real-time anatomy labeling.
Images and patients
Ultrasound · Multi-region
Key limitation
Auto EF is adult-only and adjunctive. AI FAST labels anatomy during cardiac, lung, and abdominal scanning but does not replace image interpretation. Confirm the exact hardware, software, probe, and feature configuration.

Overview status: Field-derived fact summary This section is assembled from the sourced field records below; it is not a source-reviewed editorial overview.

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • Imaging and anatomyUltrasound · Multi-region
  • Workflow rolePoint-of-care ultrasound acquisition, measurement, auscultation, adult ejection-fraction assistance, and real-time anatomy labeling.
  • Required inputReal-time ultrasound, synchronized ECG, and digital auscultation signals from compatible Kosmos hardware.
  • Output and human actionUltrasound images, clips, measurements, auscultation information, adult LVEF estimates, and AI FAST anatomy labels.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Kosmos acquires, processes, displays, measures, and stores ultrasound with synchronized ECG and digital auscultation across cardiac, lung, abdominal, vascular, musculoskeletal, and interventional applications. Adult-only Auto EF and AI FAST are adjunct functions.
  • Exact FDA submission
  • Checked 2026-09-03
Workflow role
Point-of-care ultrasound acquisition, measurement, auscultation, adult ejection-fraction assistance, and real-time anatomy labeling.
  • Exact FDA submission
  • Checked 2026-09-03
Required input
Real-time ultrasound, synchronized ECG, and digital auscultation signals from compatible Kosmos hardware.
  • Exact FDA submission
  • Checked 2026-09-03
Output and clinician action
Ultrasound images, clips, measurements, auscultation information, adult LVEF estimates, and AI FAST anatomy labels.
  • Exact FDA submission
  • Checked 2026-09-03
Care setting
Healthcare facilities and educational settings; Auto EF is limited to adult use in healthcare facilities.
  • Exact FDA submission
  • Checked 2026-09-03
Intended users
Qualified and trained healthcare professionals in clinical care and education.
  • Exact FDA submission
  • Checked 2026-09-03
Limitations
Auto EF is adult-only and adjunctive. AI FAST labels anatomy during cardiac, lung, and abdominal scanning but does not replace image interpretation. Confirm the exact hardware, software, probe, and feature configuration.
  • Exact FDA submission
  • Checked 2026-09-03
Evidence summary
K233826 defines the exact broad imaging, adult Auto EF, and AI FAST indications. A 100-patient peer-reviewed AutoEF evaluation reported strong agreement with reference echocardiography but is product-family evidence unless the tested build is mapped to K233826.
  • Exact FDA submission
  • Checked 2026-09-03

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
K233826 defines the exact broad imaging, adult Auto EF, and AI FAST indications. A 100-patient peer-reviewed AutoEF evaluation reported strong agreement with reference echocardiography but is product-family evidence unless the tested build is mapped to K233826.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-03
Reported sensitivity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Sensitivity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or dose-delivery function. Use the task-specific endpoints and tested population reported below.

Reported specificity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Specificity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or dose-delivery function. Use the task-specific endpoints and tested population reported below.

AutoEF intraclass correlation

0.85 ICC

  • EndpointAutomated versus reference LVEF
  • PopulationKosmos
  • Tested versionKosmos product family

AutoEF correlation

0.87 Pearson r

  • EndpointAutomated versus reference LVEF
  • PopulationKosmos
  • Tested versionKosmos product family

K233826 FDA performance package for Kosmos

  • DesignManufacturer system, probe, acoustic-output, image-quality, Auto EF, AI FAST, ECG, auscultation, software, and usability verification
  • PopulationRepresentative cardiac, lung, abdominal, vascular, musculoskeletal, and interventional point-of-care studies
  • Scopeexact submission
  • Tested versionKosmos release cleared in K233826
  • IndependenceSponsor or vendor study

K233826

Manufacturer evidence submitted for substantial equivalence; local clinical, technical, and workflow acceptance remains necessary.

AI-assisted ejection fraction assessment with handheld ultrasound

  • DesignProspective consecutive-patient agreement study
  • Population100 patients; 61% male and 38 with LVEF below 50%
  • Scopeproduct family
  • Tested versionKosmos product family; exact K233826 build not established
  • Samplen=100
  • IndependenceIndependent study

PMID 36713988

Product-family evidence; agreement does not establish interchangeability for every patient or release.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K233826 by exact submission identifier.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-03

A zero-result exact-identifier search does not prove that no recall, correction, adverse-event report, or product-family safety signal exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

Reimbursement
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the device within the applicable imaging or surgical service line and verify payer, site-of-service, and coding assumptions independently.
  • Service-level, not product-specific
  • Checked 2026-09-03

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

Build a local total-cost and value model; do not infer reimbursement from FDA clearance.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Real-time ultrasound, synchronized ECG, and digital auscultation signals from compatible Kosmos hardware.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-03 · K233826 FDA decision source

  2. Routing

    Source context, not route validation: Image storage and DICOM or enterprise connectivity depend on exact configuration; test measurement preservation, identifiers, image scaling, clips, and reports.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-03 · K233826 FDA decision source · Kosmos point-of-care ultrasound product family · Artificial-intelligence-assisted ejection fraction assessment with a handheld ultrasound device

  3. AI processing

    Source context, not route validation: Portable point-of-care ultrasound platform with compatible probes and tablet or display hardware.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-03 · K233826 FDA decision source · Kosmos point-of-care ultrasound product family · Artificial-intelligence-assisted ejection fraction assessment with a handheld ultrasound device

  4. Returned objects

    Source context, not route validation: Ultrasound images, clips, measurements, auscultation information, adult LVEF estimates, and AI FAST anatomy labels.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-03 · K233826 FDA decision source

  5. Viewer/worklist/report

    Unresolved route: Ultrasound images, clips, measurements, auscultation information, adult LVEF estimates, and AI FAST anatomy labels.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-03 · K233826 FDA decision source

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Portable point-of-care ultrasound platform with compatible probes and tablet or display hardware.
  • Exact FDA submission
  • Checked 2026-09-03
Integration
Image storage and DICOM or enterprise connectivity depend on exact configuration; test measurement preservation, identifiers, image scaling, clips, and reports.
  • Exact FDA submission
  • Checked 2026-09-03
Security
Current vendor materials describe HIPAA and SOC 2 controls for the product family. Obtain the exact deployment architecture, report, scope, data flow, retention, support access, and incident-response evidence.
  • Product family
  • Checked 2026-09-03

Confirm the controls against the exact contracted architecture and release.

Training
Only qualified and trained healthcare professionals in clinical care and education. should operate or interpret the system. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • Exact FDA submission
  • Checked 2026-09-03
Monitoring
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Auto EF is adult-only and adjunctive. AI FAST labels anatomy during cardiac, lung, and abdominal scanning but does not replace image interpretation. Confirm the exact hardware, software, probe, and feature configuration.
  • Exact FDA submission
  • Checked 2026-09-03

Release and scope verification

Map the installed model, build, options, population, anatomy, inputs, and outputs to K233826 before acceptance.

exact submission · checked 2026-09-03

Later product-family features are not evidence that this cleared release includes them.

Interoperability acceptance

Image storage and DICOM or enterprise connectivity depend on exact configuration; test measurement preservation, identifiers, image scaling, clips, and reports.

exact submission · checked 2026-09-03

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Auto EF is adult-only and adjunctive. AI FAST labels anatomy during cardiac, lung, and abdominal scanning but does not replace image interpretation. Confirm the exact hardware, software, probe, and feature configuration.

exact submission · checked 2026-09-03

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-03

Vendor productivity claims are scenario inputs, not guaranteed local savings.

Lifecycle monitoring

Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Auto EF is adult-only and adjunctive. AI FAST labels anatomy during cardiac, lung, and abdominal scanning but does not replace image interpretation. Confirm the exact hardware, software, probe, and feature configuration.

exact submission · checked 2026-09-03

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K233826
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-03
Anatomy
Multi-region
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-03
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2024-08-29
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
24Fields reviewed
9Source classes checked
20Awaiting review PubMed leads
10Awaiting review trial leads
0Unreviewed FDA recall leads

Recovered from the prior exact-submission extraction and normalized under the current provenance rules. Exact FDA materials, current product-family sources, selected clinical literature, reimbursement context, and exact-identifier recall candidates were reviewed. Pricing, contracted services, enabled options, final security architecture, and local interoperability remain organization-specific evidence. Automated exact-name discovery found 20 PubMed and 10 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads remain unpublished until a human confirms the exact product and tested version.

Source classes: fda ai list, fda decision summary, vendor product page, peer reviewed publication, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission

    No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed

8 sources - 2 history items

Source ledger

  1. K233826 FDA decision source

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, purpose, modality, anatomy

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. Kosmos point-of-care ultrasound product family

    EchoNous - Accessed 2026-09-03

    Scope: productFamily, workflowRole, security, training, implementationCapabilities, currentCommercialContext

  8. Artificial-intelligence-assisted ejection fraction assessment with a handheld ultrasound device

    European Heart Journal - Digital Health - Accessed 2026-09-03

    Scope: limitations, evidenceSummary, evidenceStudy, evidenceMetrics, monitoring

Research history

  1. K233826 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

Alternatives

Related tools to compare

FDA-cleared K231966

LOGIQ E10

GE Medical Systems Ultrasound and Primary care Diagnostics

Authorized purpose: LOGIQ E10 is a general-purpose diagnostic ultrasound system for broad adult and pediatric applications; K231966 adds AI-assisted renal measurements, anatomy-based preset and color suggestions, cardiac analysis, raw-data streaming, and Vscan Air CL support.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2023-11-07
FDA-cleared K201012

EPIQ Diagnostic Ultrasound System Series, Affiniti Diagnostic Ultrasound System Series, CX50 Diagnostic Ultrasound System, Sparq Diagnostic Ultrasound System, Lumify Diagnostic Ultrasound System

Philips Ultrasound, Inc.

Authorized purpose: The K201012 labeling covers Philips EPIQ, Affiniti, CX50, Sparq, and Lumify diagnostic ultrasound systems plus QLAB image viewing and quantification for labeled abdominal, cardiac, vascular, obstetric, gynecologic, pediatric, musculoskeletal, small-organ, urologic, intraoperative, and other ultrasound workflows.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2020-05-01
FDA-cleared K251963

LOGIQ E10s

Ge Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: LOGIQ E10s is a general-purpose diagnostic ultrasound system supporting the labeled adult, pediatric, cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal, urologic, and procedural applications.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-29

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history